Ganciclovir treatment of cytomegalovirus disease in transplant recipients and other immunocompromised hosts.

PubWeight™: 1.84‹?› | Rank: Top 3%

🔗 View Article (PMID 3035246)

Published in JAMA on June 12, 1987

Authors

A Erice, M C Jordan, B A Chace, C Fletcher, B J Chinnock, H H Balfour

Articles citing this

Infections in solid-organ transplant recipients. Clin Microbiol Rev (1997) 2.86

Resistance of human cytomegalovirus to antiviral drugs. Clin Microbiol Rev (1999) 2.05

New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients. Clin Microbiol Rev (2000) 1.75

Cytomegalovirus infection in the gastrointestinal tract. J Clin Pathol (1994) 1.25

Use of A-549 cells in a clinical virology laboratory. J Clin Microbiol (1988) 1.17

OKT3 and viral disease in pediatric liver transplant recipients. Clin Transplant (1991) 1.11

Acquisition of cytomegalovirus infection: an update. Clin Microbiol Rev (1989) 0.91

Cytomegalovirus myocarditis following liver transplantation. Postgrad Med J (1994) 0.89

Population differences in ganciclovir clearance as determined by nonlinear mixed-effects modelling. Antimicrob Agents Chemother (1995) 0.87

Electronic estimations of renal function are inaccurate in solid-organ transplant recipients and can result in significant underdosing of prophylactic valganciclovir. Antimicrob Agents Chemother (2013) 0.86

Therapeutic use of ganciclovir for invasive cytomegalovirus infection in cadaveric renal allograft recipients. J Urol (1992) 0.85

Toxicity trial of prophylactic 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine (ganciclovir) after marrow transplantation in dogs. Antimicrob Agents Chemother (1988) 0.83

Specific ablation of human immunodeficiency virus Tat-expressing cells by conditionally toxic retroviruses. Proc Natl Acad Sci U S A (1994) 0.81

Use of cytomegalovirus intravenous immune globulin for the adjunctive treatment of cytomegalovirus in hematopoietic stem cell transplant recipients. Pharmacotherapy (2010) 0.80

Cytomegalovirus retinitis in a patient with dermatomyositis. Clin Rheumatol (2006) 0.78

Ganciclovir pharmacokinetics during renal impairment. Antimicrob Agents Chemother (1988) 0.77

Recovery of human immunodeficiency virus type 1 from supernatant fluid of routine viral cultures. J Clin Microbiol (1989) 0.75

Specific and non-specific serological markers in the screening for congenital CMV infection. Epidemiol Infect (1988) 0.75

Fatal lactic acidosis possibly related to ganciclovir therapy in a renal transplant patient? Indian J Crit Care Med (2015) 0.75

Utility of bronchoscopy with bronchoalveolar lavage in diagnosing pulmonary infection in hospitalized patients with underlying malignancy. Can J Infect Dis (1998) 0.75

Visual symptoms in patients on cyclophosphamide may herald sight threatening disease. Br J Ophthalmol (2003) 0.75

CMV in Hematopoietic Stem Cell Transplantation. Mediterr J Hematol Infect Dis (2016) 0.75

AIDS-associated cytomegalovirus infection of the submandibular gland mimicking a tumour. J R Soc Med (1994) 0.75

Continuous infusion of high-dose acyclovir for serious herpesvirus infections. Antimicrob Agents Chemother (1989) 0.75

Comparison of monoclonal antibodies for rapid detection of cytomegalovirus in spin-amplified plate cultures. J Clin Microbiol (1989) 0.75

Articles by these authors

Functional annotation of a full-length mouse cDNA collection. Nature (2001) 23.61

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. N Engl J Med (1997) 17.51

The natural history of chronic airflow obstruction. Br Med J (1977) 13.04

Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases. N Engl J Med (1990) 12.00

RJR Nabisco's cartoon camel promotes camel cigarettes to children. JAMA (1991) 7.07

The complete genome of the crenarchaeon Sulfolobus solfataricus P2. Proc Natl Acad Sci U S A (2001) 7.00

Virus-associated hemophagocytic syndrome: a benign histiocytic proliferation distinct from malignant histiocytosis. Cancer (1979) 5.60

Differentiation and reversal of malignant changes in colon cancer through PPARgamma. Nat Med (1998) 5.16

Quantitative image analysis of HIV-1 infection in lymphoid tissue. Science (1996) 4.72

Consultation skills of young doctors: I--Benefits of feedback training in interviewing as students persist. Br Med J (Clin Res Ed) (1986) 4.62

Bacterial pneumonia in persons infected with the human immunodeficiency virus. Pulmonary Complications of HIV Infection Study Group. N Engl J Med (1995) 3.80

Terminal differentiation of human breast cancer through PPAR gamma. Mol Cell (1998) 3.71

Survival of influenza viruses on environmental surfaces. J Infect Dis (1982) 3.51

Cytomegalovirus disease in renal allograft recipients: a prospective study of the clinical features, risk factors and impact on renal transplantation. Medicine (Baltimore) (1980) 3.42

Brief report: primary infection with zidovudine-resistant human immunodeficiency virus type 1. N Engl J Med (1993) 3.34

A genomewide scan for loci predisposing to type 2 diabetes in a U.K. population (the Diabetes UK Warren 2 Repository): analysis of 573 pedigrees provides independent replication of a susceptibility locus on chromosome 1q. Am J Hum Genet (2001) 3.26

Epstein-Barr virus (EBV) induced polyclonal and monoclonal B-cell lymphoproliferative diseases occurring after renal transplantation. Clinical, pathologic, and virologic findings and implications for therapy. Ann Surg (1983) 3.15

A randomized, placebo-controlled trial of oral acyclovir for the prevention of cytomegalovirus disease in recipients of renal allografts. N Engl J Med (1989) 2.78

Progressive disease due to ganciclovir-resistant cytomegalovirus in immunocompromised patients. N Engl J Med (1989) 2.77

Analysis of the UL97 phosphotransferase coding sequence in clinical cytomegalovirus isolates and identification of mutations conferring ganciclovir resistance. J Infect Dis (1995) 2.65

Sequence interpretation. Functional annotation of mouse genome sequences. Science (2001) 2.54

Herpes simplex virus resistant to acyclovir. A study in a tertiary care center. Ann Intern Med (1990) 2.53

Listening and talking to patients. III: The exposition. Br Med J (1980) 2.48

Failure of automatic control of ventilation (Ondine's curse). Report of an infant born with this syndrome and review of the literature. Medicine (Baltimore) (1970) 2.44

Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation. N Engl J Med (1982) 2.44

Ganciclovir-resistant cytomegalovirus clinical isolates: mode of resistance to ganciclovir. Antimicrob Agents Chemother (1991) 2.40

A survey of doctors' attitudes to smoking. Br J Prev Soc Med (1969) 2.39

Transcription factor OTF-1 is functionally identical to the DNA replication factor NF-III. Science (1988) 2.31

Latent infection and the elusive cytomegalovirus. Rev Infect Dis (1983) 2.24

Rapid and sensitive viral culture method for human immunodeficiency virus type 1. J Clin Microbiol (1988) 2.22

Antiviral susceptibilities and analysis of UL97 and DNA polymerase sequences of clinical cytomegalovirus isolates from immunocompromised patients. J Infect Dis (1997) 2.18

Monitoring plasma HIV-1 RNA levels in addition to CD4+ lymphocyte count improves assessment of antiretroviral therapeutic response. ACTG 241 Protocol Virology Substudy Team. Ann Intern Med (1997) 2.06

Disseminated cytomegalovirus infection. Molecular analysis of virus and leukocyte interactions in viremia. J Clin Invest (1988) 2.05

Viability and functional activity of cryopreserved mononuclear cells. Clin Diagn Lab Immunol (2000) 2.05

Cytomegalovirus (CMV) antigenemia assay is more sensitive than shell vial cultures for rapid detection of CMV in polymorphonuclear blood leukocytes. J Clin Microbiol (1992) 1.99

High-dose nevirapine: safety, pharmacokinetics, and antiviral effect in patients with human immunodeficiency virus infection. J Infect Dis (1995) 1.97

Acyclovir therapy for acute herpes zoster. Lancet (1982) 1.95

Acyclovir halts progression of herpes zoster in immunocompromised patients. N Engl J Med (1983) 1.90

Therapy of herpes zoster with oral acyclovir. Am J Med (1988) 1.89

Human immunodeficiency virus type 1 detected in all seropositive symptomatic and asymptomatic individuals. J Clin Microbiol (1990) 1.88

Shamed into anger? The relation of shame and guilt to anger and self-reported aggression. J Pers Soc Psychol (1992) 1.87

Rubella viraemia and antibody responses after rubella vaccination and reimmunization. Lancet (1981) 1.86

Specific cell-mediated immune defect in active cytomegalovirus infection of young children and their mothers. Lancet (1977) 1.85

Association of cervical cytomegaloviruses with venereal disease. N Engl J Med (1973) 1.84

Schistosoma mansoni: chemotherapy of infections of different ages. Exp Parasitol (1986) 1.84

Performance characteristics of serologic tests for human immunodeficiency virus type 1 (HIV-1) antibody among Minnesota blood donors. Public health and clinical implications. Ann Intern Med (1989) 1.84

Phenotypic and genotypic characterization of acyclovir-resistant herpes simplex viruses from immunocompromised patients. J Infect Dis (1998) 1.83

An outbreak of herpes gladiatorum at a high-school wrestling camp. N Engl J Med (1991) 1.80

Immunosuppression reactivates and disseminates latent murine cytomegalovirus. J Gen Virol (1977) 1.79

Transmission of hepatitis B virus in clinical laboratory areas. J Infect Dis (1979) 1.77

Multicenter comparison of different real-time PCR assays for quantitative detection of Epstein-Barr virus. J Clin Microbiol (2007) 1.77

Respiratory syncytial virus infection in immunocompromised adults. Ann Intern Med (1988) 1.75

Clinical pharmacology of carbenicillin compared with other penicillins. J Infect Dis (1970) 1.68

Spontaneous cytomegalovirus mononucleosis. Clinical and laboratory observations in nine cases. Ann Intern Med (1973) 1.65

High levels of circulating cytomegalovirus DNA reflect visceral organ disease in viremic immunosuppressed patients other than marrow recipients. J Clin Invest (1992) 1.62

California arbovirus (La Crosse) infections. I. Clinical and laboratory findings in 66 children with meningoencephalitis. Pediatrics (1973) 1.62

Trisomies 8 and 20 in desmoid tumors. Cancer Genet Cytogenet (1996) 1.61

Practical diagnostic testing for human immunodeficiency virus. Clin Microbiol Rev (1988) 1.61

Morphine promotes the growth of HIV-1 in human peripheral blood mononuclear cell cocultures. AIDS (1990) 1.61

Human immunodeficiency virus infection in patients with solid-organ transplants: report of five cases and review. Rev Infect Dis (1991) 1.58

Acyclovir therapy for mucocutaneous herpes simplex infections in immunocompromised patients. Lancet (1981) 1.58

Recovery of human immunodeficiency virus from ocular tissues in patients with acquired immune deficiency syndrome. Ophthalmology (1988) 1.57

Human pharmacokinetics of the antiviral drug DHPG. Clin Pharmacol Ther (1986) 1.57

Latent murine cytomegalovirus DNA in splenic stromal cells of mice. J Virol (1991) 1.55

Hemophiliacs with HIV antibody are actively infected. JAMA (1988) 1.55

Novel mutation in the UL97 gene of a clinical cytomegalovirus strain conferring resistance to ganciclovir. Antimicrob Agents Chemother (1995) 1.55

Use of intravitreal ganciclovir (dihydroxy propoxymethyl guanine) for cytomegalovirus retinitis in a patient with AIDS. Am J Ophthalmol (1987) 1.54

Encephalitis associated with erythema infectiosum. J Pediatr (1970) 1.51

Visceral leishmaniasis in patients infected with human immunodeficiency virus. Co-operative Group for the Study of Leishmaniasis in AIDS. J Infect (1990) 1.50

Overlapping roles of pocket proteins in the myocardium are unmasked by germ line deletion of p130 plus heart-specific deletion of Rb. Mol Cell Biol (2005) 1.48

Neurological outcomes in late HIV infection: adverse impact of neurological impairment on survival and protective effect of antiviral therapy. AIDS Clinical Trial Group and Neurological AIDS Research Consortium study team. AIDS (1999) 1.48

Demographic and dietary determinants of constipation in the US population. Am J Public Health (1990) 1.47

Parainfluenza virus respiratory infection after bone marrow transplantation. N Engl J Med (1992) 1.47

Comparison of quantitative and qualitative PCR assays for cytomegalovirus DNA in plasma. J Clin Microbiol (2001) 1.45

Acyclovir therapy in neonates. J Pediatr (1991) 1.45

Clinical characteristics of the lethal cytomegalovirus infection following renal transplantation. Surgery (1977) 1.45

Inducible activation of c-Myc in adult myocardium in vivo provokes cardiac myocyte hypertrophy and reactivation of DNA synthesis. Circ Res (2001) 1.44

Modification by adoptive humoral immunity of murine cytomegalovirus infection. J Infect Dis (1981) 1.43

Cytomegalovirus viremia detected by molecular hybridization and electron microscopy. Ann Intern Med (1984) 1.43

Left ventricular unloading during reperfusion does not limit myocardial infarct size. Circulation (1990) 1.43

Physical trauma and breast cancer. Lancet (1994) 1.42

Interlaboratory concordance of DNA sequence analysis to detect reverse transcriptase mutations in HIV-1 proviral DNA. ACTG Sequencing Working Group. AIDS Clinical Trials Group. J Virol Methods (1998) 1.41

The duration of zidovudine benefit in persons with asymptomatic HIV infection. Prolonged evaluation of protocol 019 of the AIDS Clinical Trials Group. JAMA (1994) 1.41

Allescheria boydii infections in the immunosuppressed host. Am J Med (1977) 1.40

Cytomegalovirus infection after bone marrow transplantation: an association with acute graft-v-host disease. Blood (1986) 1.40

Interactions of human cytomegalovirus with leukocytes in vivo: analysis by in situ hybridization. Microb Pathog (1987) 1.39

Sir William Osler's gown returns home. Br Med J (Clin Res Ed) (1985) 1.39

Clinical and laboratory evaluation of cytomegalovirus-induced mononucleosis in previously healthy individuals. Report of 82 cases. Medicine (Baltimore) (1986) 1.38

Consultation skills of young doctors: II--Most young doctors are bad at giving information. Br Med J (Clin Res Ed) (1986) 1.37